XKRX:012790 (Korea (the Republic of))
Â
â‚©
6,440
-180 (-2.72%)
Feb 28
Business Description
Sinil Pharmaceutical Co Ltd
SIC : 111
ISIN : KR7012790002
Compare
Compare
Traded in other countries / regions
012790.Korea Index Membership
KOSDAQ Composite Index IPO Date
1999-08-13Description
Sinil Pharmaceutical Co Ltd is a South Korean drug manufacturing company. The products of the company include diphene gel, tour pen plasta, oriental herb tea cold liquid, and griffen ssung.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 69.02 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 679.9 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.18 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 17.3 | |||||
| 3-Year EPS without NRI Growth Rate | 24.3 | |||||
| 3-Year FCF Growth Rate | -4.8 | |||||
| 3-Year Book Growth Rate | 6.9 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.27 | |||||
| 9-Day RSI | 40.06 | |||||
| 14-Day RSI | 43.08 | |||||
| 3-1 Month Momentum % | 0.46 | |||||
| 6-1 Month Momentum % | -13.21 | |||||
| 12-1 Month Momentum % | -7.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5 | |||||
| Quick Ratio | 3.51 | |||||
| Cash Ratio | 2.23 | |||||
| Days Inventory | 158.79 | |||||
| Days Sales Outstanding | 81.65 | |||||
| Days Payable | 35.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.13 | |||||
| 3-Year Dividend Growth Rate | 23.3 | |||||
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | -0.51 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.65 | |||||
| Operating Margin % | 16.45 | |||||
| Net Margin % | 16.43 | |||||
| FCF Margin % | 23 | |||||
| ROE % | 10.97 | |||||
| ROA % | 9.69 | |||||
| ROIC % | 11.03 | |||||
| 3-Year ROIIC % | 42.24 | |||||
| ROC (Joel Greenblatt) % | 23.49 | |||||
| ROCE % | 12.01 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 4.94 | |||||
| PE Ratio without NRI | 4.94 | |||||
| Price-to-Owner-Earnings | 7.71 | |||||
| PEG Ratio | 0.33 | |||||
| PS Ratio | 0.81 | |||||
| PB Ratio | 0.52 | |||||
| Price-to-Tangible-Book | 0.53 | |||||
| Price-to-Free-Cash-Flow | 3.53 | |||||
| Price-to-Operating-Cash-Flow | 2.82 | |||||
| EV-to-EBIT | 2.51 | |||||
| EV-to-EBITDA | 2.49 | |||||
| EV-to-Revenue | 0.46 | |||||
| EV-to-FCF | 2.01 | |||||
| Price-to-GF-Value | 0.69 | |||||
| Price-to-Projected-FCF | 0.37 | |||||
| Price-to-Median-PS-Value | 0.43 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.4 | |||||
| Price-to-Graham-Number | 0.34 | |||||
| Price-to-Net-Current-Asset-Value | 1.34 | |||||
| Price-to-Net-Cash | 4.83 | |||||
| Earnings Yield (Greenblatt) % | 39.84 | |||||
| FCF Yield % | 28.34 | |||||
| Forward Rate of Return (Yacktman) % | 20.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinil Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 91,699.141 | ||
| EPS (TTM) (â‚©) | 1304 | ||
| Beta | 0.87 | ||
| 3-Year Sharpe Ratio | -0.35 | ||
| 3-Year Sortino Ratio | -0.46 | ||
| Volatility % | 15.95 | ||
| 14-Day RSI | 43.08 | ||
| 14-Day ATR (â‚©) | 120.985685 | ||
| 20-Day SMA (â‚©) | 6511.5 | ||
| 12-1 Month Momentum % | -7.46 | ||
| 52-Week Range (â‚©) | 5920 - 8430 | ||
| Shares Outstanding (Mil) | 11.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinil Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinil Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinil Pharmaceutical Co Ltd Frequently Asked Questions
What is Sinil Pharmaceutical Co Ltd(XKRX:012790)'s stock price today?
The current price of XKRX:012790 is â‚©6440.00. The 52 week high of XKRX:012790 is â‚©8430.00 and 52 week low is â‚©5920.00.
When is next earnings date of Sinil Pharmaceutical Co Ltd(XKRX:012790)?
The next earnings date of Sinil Pharmaceutical Co Ltd(XKRX:012790) is .
Does Sinil Pharmaceutical Co Ltd(XKRX:012790) pay dividends? If so, how much?
Sinil Pharmaceutical Co Ltd(XKRX:012790) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers